Brendan Hannah, Chief Business Officer: Quince Therapeutics QNCX Buy · Filed 23/08/09

Trade details

Type: Insider buy
Amount: $87,549.64
Shares · price: 71,762 sh · $1.22 a share
Held after: 201,555 sh
Stock: Quince Therapeutics QNCX
Person: Brendan HannahChief Business Officer
Trade date: 23/08/08
Filed: 23/08/09
Days to filing: 1 days

4 insiders bought this week

Insiders buying this week: 4 insiders
Holding change: +55.3%

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 23/07/09~23/09/07

Brendan Hannah's recent trades

Brendan HannahChief Business Officer and COO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$14.8K
23,565 sh
$14.8K
Filed 24/08/21
Traded 24/08/21
Brendan HannahChief Business Officer and COO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$1,391
2,280 sh
$1,391
Filed 24/08/21
Traded 24/08/21
Brendan HannahChief Business Officer and COO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$2,054
3,424 sh
$2,054
Filed 24/08/21
Traded 24/08/20
Brendan HannahChief Business Officer and COO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$3,100
5,000 sh
$3,100
Filed 24/08/21
Traded 24/08/21
Brendan HannahChief Business Officer and COO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$1,250
2,155 sh
$1,250
Filed 24/08/21
Traded 24/08/19